- Home
- CREX vs SONN Comparison
CREX vs SONN Comparison
Compare CREX & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREX
- SONN
- Stock Information
- Founded
- CREX N/A
- SONN N/A
- Country
- CREX United States
- SONN United States
- Employees
- CREX N/A
- SONN N/A
- Industry
- CREX EDP Services
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- CREX Technology
- SONN Health Care
- Exchange
- CREX Nasdaq
- SONN Nasdaq
- Market Cap
- CREX 25.7M
- SONN 21.4M
- IPO Year
- CREX N/A
- SONN N/A
- Fundamental
- Price
- CREX N/A
- SONN $5.00
- Analyst Decision
- CREX Strong Buy
- SONN Strong Buy
- Analyst Count
- CREX 1
- SONN 1
- Target Price
- CREX $6.00
- SONN $20.00
- AVG Volume (30 Days)
- CREX 33.3K
- SONN 1.6M
- Earning Date
- CREX 11-12-2025
- SONN 08-13-2025
- Dividend Yield
- CREX N/A
- SONN N/A
- EPS Growth
- CREX N/A
- SONN N/A
- EPS
- CREX N/A
- SONN N/A
- Revenue
- CREX $48,218,000.00
- SONN $1,000,000.00
- Revenue This Year
- CREX $4.82
- SONN $5,376.22
- Revenue Next Year
- CREX $18.60
- SONN N/A
- P/E Ratio
- CREX N/A
- SONN N/A
- Revenue Growth
- CREX N/A
- SONN 1689.52
- 52 Week Low
- CREX $1.28
- SONN $1.08
- 52 Week High
- CREX $4.75
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- CREX N/A
- SONN 51.69
- Support Level
- CREX N/A
- SONN $4.90
- Resistance Level
- CREX N/A
- SONN $6.15
- Average True Range (ATR)
- CREX 0.00
- SONN 0.77
- MACD
- CREX 0.00
- SONN -0.13
- Stochastic Oscillator
- CREX 0.00
- SONN 31.33
About CREX Creative Realities Inc.
Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.